PBPK, QSP & biosimulationconfirmed
Simulations Plus
Modeling and simulation software and services, including DILIsym quantitative systems toxicology.
Notable
Bought Immunetrics (Jun 2023). Cut FY2025 guidance mid-year. A law firm announced a securities inquiry in Jul 2026 citing an impairment charge and an auditor dispute.
Related deals
No tracked deals yet.
Related updates
- Jul 6, 2026Simulations Plus faces law-firm inquiry after guidance cutprnewswire.com(opens in new tab)